To ask the Secretary of State for Health and Social Care, whether his Department has made a recent assessment of the effectiveness of measures to protect people who are most vulnerable from covid-19; and whether he plans to make an assessment of the potential merits of implementing such measures.
The UK Health Security Agency’s COVID-19 vaccine surveillance report shows that as of 21 April 2022, vaccine uptake among those identified as severely immunosuppressed was 95.7% for at least one dose, 94.5% for at least two doses and 88.1% for at least three doses. NHS England’s COVID Therapeutics data for the week ending 22 May 2022 shows that the number of non-hospitalised people in England who have received antivirals or neutralising monoclonal antibody treatments is 45,745. The Office for National Statistics’ survey ‘Coronavirus and clinically extremely vulnerable people in England’ published on 13 May shows that 81% of respondents were aware of guidance for people whose immune system means they are at higher risk. We have no plans to make a further assessment of the current measures which are in place.